LEO 153339
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LEO 153339, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults [Phase 1]